Advertisment

Indian Journal of Nephrology About us |  Subscription |  e-Alerts  | Feedback | Login   
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 Home | Current Issue | Archives| Ahead of print | Search |Instructions |  Editorial Board  

Users Online:190

Official publication of the Indian Society of Nephrology
  ~   Site Statistics 
  ~   Addresses 
  ~   Search 
  ~   My Preferences 
  ~   Online Submission 

 


This article has been cited by
1Renal Tubular Toxicity Associated With Rosuvastatin Therapy
Frank L. Ward,Rohan John,Joanne M. Bargman,Rory F. McQuillan
American Journal of Kidney Diseases.2017;69(3)473
[DOI]
2Influence of statin-potency on the risk of kidney disease – A nationwide cohort study using laboratory data
Anna Citarella,Marie Linder,Simona Cammarota,Anders Sundström,Helle Kieler
Pharmacoepidemiology and Drug Safety.2021;30(2)210
[DOI]
3Statins: Adverse reactions, oxidative stress and metabolic interactions
Aimei Liu,Qinghua Wu,Jingchao Guo,Irma Ares,José-Luis Rodríguez,María-Rosa Martínez-Larrañaga,Zonghui Yuan,Arturo Anadón,Xu Wang,María-Aránzazu Martínez
Pharmacology & Therapeutics.2019;195(2)54
[DOI]
4Ontology-based systematical representation and drug class effect analysis of package insert-reported adverse events associated with cardiovascular drugs used in China
Liwei Wang,Mei Li,Jiangan Xie,Yuying Cao,Hongfang Liu,Yongqun He
Scientific Reports.2017;7(1)54
[DOI]
5Association between incidental statin use and skeletal myopathies in patients treated with immune checkpoint inhibitors
Zsofia D Drobni,Sean P Murphy,Raza M Alvi,Charlotte Lee,Jingyi Gong,Ramya C Mosarla,Paula K Rambarat,Sarah B Hartmann,Hannah K Gilman,Leyre Zubiri,Vineet K Raghu,Ryan J Sullivan,Amna Zafar,Daniel A Zlotoff,Meghan E Sise,Amanda C Guidon,Kerry L Reynolds,Michael Dougan,Tomas G Neilan
Immunotherapy Advances.2021;1(1)54
[DOI]
6Renal Function after Fenestrated or Branched Endovascular Aortic Repair: The Early Impairment Predictive Factors
Meryl Favier de Lachomette,Nellie Della,Delphine Maucort-Boulch,Ambroise Duprey,Eugenio Rosset,Patrick Feugier,Patrick Lermusiaux,Jean-Noël Albertini,Antoine Millon
Annals of Vascular Surgery.2017;40(1)1
[DOI]
7Do statins induce or protect from acute kidney injury and chronic kidney disease: An update review in 2018
An Verdoodt,Patrick M. Honore,Rita Jacobs,Elisabeth De Waele,Viola Van Gorp,Jouke De Regt,Herbert D. Spapen
Journal of Translational Internal Medicine.2018;6(1)21
[DOI]
8Acute kidney injury post coronary angioplasty
Sachin Motiram Naik,Shubham Shukla,Jasmine Sethi,Aravind Sekar
BMJ Case Reports.2022;15(3)e249294
[DOI]
9RE: Praluent (Alirocumab)-Induced Renal Injury
Robert S. Rosenson,Dominique Larrey,David D. Waters,Anders G. Olsson
Journal of Pharmacy Practice.2018;31(2)138
[DOI]
10Atorvastatin/rosuvastatin
Robert S. Rosenson,Dominique Larrey,David D. Waters,Anders G. Olsson
Reactions Weekly.2015;1539(1)55
[DOI]
11Rosuvastatin Induces Renal HO-1 Activity and Expression Levels as a Main Protective Mechanism against STZ-Induced Diabetic Nephropathy
Gehan H. Heeba,Marwa A. M. Ali,Azza A. K. El-Sheikh
Medicina.2022;58(3)425
[DOI]
12The main side effects of statins in clinical practice
Aleksey M. Chaulin
Journal of Clinical Practice.2022;13(2)98
[DOI]
13Cardiorenal Syndrome Triggered by Slowly Progressive Drugs Toxicity-Induced Renal Failure along with Minimal Mitral Disease: A Case Report
Carlo Caiati,Adriana Argentiero,Stefano Favale,Mario Erminio Lepera
Endocrine, Metabolic & Immune Disorders - Drug Targets.2022;22(9)970
[DOI]
© Indian Journal of Nephrology
Published by Wolters Kluwer - Medknow
Online since 20th Sept '07